New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 1, 2014
11:03 EDTELY, BBG, INFA, GALT, IPGHigh option volume stocks: BBG IPG INFA ELY GALT
News For BBG;IPG;INFA;ELY;GALT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 31, 2015
10:09 EDTBBGHigh option volume stocks
Subscribe for More Information
March 26, 2015
07:24 EDTIPGWells Fargo to hold a forum
Subscribe for More Information
March 25, 2015
10:00 EDTINFAOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: AB InBev (BUD) downgraded to Reduce from Overweight at HSBC... BreitBurn Energy (BBEP) downgraded to Sell from Neutral at UBS... DiamondRock (DRH) downgraded to Reduce from Neutral at SunTrust... Ethan Allen (ETH) downgraded to Hold from Buy at Gabelli... Felcor Lodging (FCH) downgraded to Neutral from Buy at SunTrust... Finish Line (FINL) downgraded to Neutral from Buy at B. Riley... Hannover Re (HVRRY) downgraded to Sell from Hold at Deutsche Bank... Hersha Hospitality (HT) downgraded to Reduce from Neutral at SunTrust... Host Hotels (HST) downgraded to Reduce from Neutral at SunTrust... ING Groep (ING) downgraded to Neutral from Buy at Goldman... Informatica (INFA) downgraded to Neutral from Buy at Mizuho... Kofax (KFX) downgraded to Hold from Buy at Canaccord... LRR Energy (LRE) downgraded to Sell from Neutral at UBS... LaSalle Hotel (LHO) downgraded to Reduce from Neutral at SunTrust... Munich Re (MURGY) downgraded to Sell from Hold at Deutsche Bank... Orbital ATK (OA) downgraded to Market Perform from Outperform at Wells Fargo... PCTEL, Inc. (PCTI) downgraded to Neutral from Buy at B. Riley... Quest Diagnostics (DGX) downgraded to Hold from Buy at Deutsche Bank... SJW Corp. (SJW) downgraded to Neutral from Outperform at RW Baird... Selective Insurance (SIGI) downgraded to Neutral from Buy at BofA/Merrill... Sonus (SONS) downgraded to Hold from Buy at Wunderlich... Starwood (HOT) downgraded to Neutral from Buy at SunTrust... Synchrony Financial (SYF) downgraded to Neutral from Buy at BofA/Merrill... Tesla (TSLA) downgraded to Underperform from Outperform at CLSA... Twitter (TWTR) downgraded to Hold from Buy at Pivotal Research... ZAGG (ZAGG) downgraded to Market Perform from Outperform at Northland... iDreamSky (DSKY) downgraded to Neutral from Overweight at JPMorgan.
March 24, 2015
19:47 EDTINFAInformatica downgraded to Neutral from Buy at Mizuho
Mizuho downgraded Informatica to Neutral following the run-up in share price after reports of a potential private equity offer. Mizuho has a price target of $47 on Informatica shares.
10:09 EDTBBGHigh option volume stocks
Subscribe for More Information
March 23, 2015
10:00 EDTINFAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:00 EDTELYOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
06:49 EDTINFAInformatica downgraded to Neutral from Buy at Nomura
Subscribe for More Information
05:40 EDTELYCallaway Golf upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital upgraded Callaway Golf to Outperform citing new product sales momentum and the company's pricing initiatives. The firm raised its price target for shares to $12 from $8.
March 20, 2015
13:26 EDTINFAInformatica deal could be complicated by current price, says FBN Securities
Subscribe for More Information
13:17 EDTINFAInformatica calls active on PE firm group readying bid for report
Informatica April 42 and 45 calls are active on total call volume of 1,100 contracts (100 puts) on PE firm group readying bid, Reuters reports. April call option implied volatility is at 45, June is at 33, September is at 29; compared to its 26-week average of 27 according to Track Data. Active call volume suggests traders taking positions for large price movement.
13:10 EDTINFAPE firms readying bids for Informatica, Reuters reports
Subscribe for More Information
12:55 EDTINFAPE firm group readying bid for Informatica, Reuters reports
Subscribe for More Information
March 18, 2015
17:14 EDTGALTGalectin submitted request for SPA with clinical protocol for GR-MD-02 trial
"I am pleased with our many accomplishments during 2014 as we continue to advance programs with GR-MD-02 for the treatment of nonalcoholic steatohepatitis, NASH, with advanced fibrosis. We completed a successful Phase 1 clinical trial and announced final data in January 2015 that were supportive of our plans to begin a Phase 2 program with GR-MD-02 in advanced fatty liver disease, or NASH with fibrosis and cirrhosis," said Peter G. Traber, M.D., president, CEO and chief medical officer of Galectin Therapeutics. "As announced last month, we submitted the Phase 2 clinical trial protocol to the U.S. Food and Drug Administration, FDA, to evaluate the safety and efficacy of GR-MD-02 for the treatment of liver fibrosis and resultant portal hypertension in patients with NASH cirrhosis, the primary endpoint being to determine the change in the hepatic venous pressure gradient, HVPG, as compared with placebo. The FDA has indicated that HVPG may serve as a surrogate primary endpoint for NASH cirrhosis. We submitted a request for a Special Protocol Assessment with the clinical protocol for this trial. Additionally, we are planning to conduct a separate, shorter Phase 2 trial in NASH patients with advanced fibrosis. We expect to begin enrolling patients in both trials during the second quarter of 2015."
17:08 EDTGALTGalectin Therapeutics reports FY14 EPS (78c), consensus (77c)
As of December 31, the company had $29.1M of non-restricted cash and cash equivalents available to fund future operations. In January and February of 2015, the company received $4.1M in net proceeds from the issuance of common shares through its At-the-Market stock issuance program. The company believes that cash on hand of $29.7M as of March 13, is sufficient to fund its operations and research and development activities through September 30, 2016.
March 17, 2015
10:00 EDTBBGOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:13 EDTBBGBill Barrett downgraded to Sell from Neutral at Global Hunter
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use